Biotech · Public company · Waltham, MA, US
Q32 Bio Inc.
Ticker QTTB · SEC CIK 0001661998
Track this companyFree. Adds Q32 Bio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- ADX-914Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- bempikibart (ADX-914)Phase 2 · Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 12, 2023ClinicalTrials.gov NCT06018428 · fetched Nov 12, 2026
- Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 30, 2022ClinicalTrials.gov NCT05509023 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 16, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 27, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026